{"text": ["Why", "This", "Biotech", "Stock", "Succeeded", "In", "Colon", "Cancer", "As", "Others", "Struggled"], "created_at": "2019-05-21 20:16:45"}
{"text": ["Here's", "Why", "Array", "BioPharma", "Is", "Surging", "Today"], "created_at": "2019-05-21 18:08:55"}
{"text": ["Here's", "Why", "Array", "BioPharma", "Is", "Surging", "Today"], "created_at": "2019-05-21 18:08:55"}
{"text": ["Lilly's", "Mirikizumab", "Met", "Primary", "Endpoint", "and", "Key", "Secondary", "Endpoints", "in", "Phase", "2", "Study,", "Including", "Reductions", "of", "Gastrointestinal", "Lesions"], "created_at": "2019-05-21 17:15:00"}
{"text": ["Merck", "agrees", "$1bn", "deal", "to", "buy", "biopharmaceutical", "company", "Peloton"], "created_at": "2019-05-21 12:13:51"}
